Patent row: Delhi HC to hear diabetes drug case

Glenmark Generics, a subsidiary of Glenmark Pharmaceuticals, is recalling multiple lots of three of its drugs from the US market due to odd smell, according to US Food and Drug Administration. A notification issued by the US Food and Drug Administration said ...

Delhi high court will hear an appeal filed by US drugmaker MSD on alleged patent infringement by India's Glenmark on Wednesday C.H. Unnikrishnan The court's judgment will help define the validity of innovator companies strategy, making multiple ...

Glenmark Pharmaceuticals Ltd today said its subsidiary has received approval from the US health regulator to sell generic versions of AstraZeneca's Zomig and Zomig ZMT tablets, a migraine drug, in the American market.

with ET Now, CK Narayan of Growth Avenues Asset Advisors shares his views on Glenmark Pharma. ET Now: What are your stock recommendations? CK Narayan: Glenmark Pharma is a 'BUY' call with a target of Rs 605 and a stop loss of Rs 570. Follow Economic Times ...

Will help in the treatment of migraine headaches in adults Glenmark Generics has been granted final abbreviated new drug approvals (ANDA's) from the United States Food and Drug Administration (US FDA) for zolmitriptan tablets, 2.5 and 5mg and ...

Meanwhile, the S&P BSE Sensex was up 99.23 points or 0.49% at 20,312.19.

One can buy Glenmark Pharma, says Sudarshan Sukhani of s2analytics.com. Its charts are excellent and it is making new highs, he adds.

Pharma stocks like Dr Reddys, Lupin, Divis Labs, Glenmark and Orchid Chemicals will getting astrological support, says Satish Gupta of Astrostocktips.